Early Intervention to Promote Cardiovascular Health of Mothers and Children

Launched by JHSPH CENTER FOR CLINICAL TRIALS · Feb 15, 2024

Keywords

ClinConnect Summary

The "Early Intervention to Promote Cardiovascular Health of Mothers and Children" trial, also known as ENRICH, is a study aimed at improving heart health for mothers and their young children. The trial will look at how effective home visits from trained professionals can be in promoting better cardiovascular health and reducing health differences among families at higher risk for heart-related issues. It involves about 6,400 participants, including 3,200 parent-child pairs, and is taking place in various community settings.

To participate, mothers need to be pregnant (with one or more babies) and currently enrolled in a home visiting program that is part of this study. They must be at least 18 years old and able to speak either English or Spanish. If eligible, participants can expect to receive support and resources aimed at improving their and their child's heart health through home visits. This trial is currently recruiting participants and aims to make a positive impact on the cardiovascular health of families in communities most affected by heart disease.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Be currently enrolled in an evidence-based home visiting program participating in ENRICH
• • 2. Be pregnant, with a single or multifetal gestation, at or less than 34 weeks 0 days gestation (per self-report at time of consent)
• • 3. Be 18 years of age or older
• • 4. Speak English or Spanish
• • Exclusion Criteria: There are no exclusion criteria being applied in assessing eligibility for participation in ENRICH.